These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 30018256)
1. Breast Cancer Stem Cells. Crabtree JS; Miele L Biomedicines; 2018 Jul; 6(3):. PubMed ID: 30018256 [TBL] [Abstract][Full Text] [Related]
2. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy? Shima H; Yamada A; Ishikawa T; Endo I Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells. Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K Front Oncol; 2020; 10():452. PubMed ID: 32426267 [TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications. Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056 [TBL] [Abstract][Full Text] [Related]
5. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies. Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510 [TBL] [Abstract][Full Text] [Related]
6. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224 [TBL] [Abstract][Full Text] [Related]
7. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment. Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889 [TBL] [Abstract][Full Text] [Related]
8. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells. Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells and the challenges of eradication: a review of novel therapies. Saeg F; Anbalagan M Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750 [TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies. Romaniuk-Drapała A; Totoń E; Taube M; Idzik M; Rubiś B; Lisiak N Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001543 [TBL] [Abstract][Full Text] [Related]
11. The Breast Cancer Stem Cells Traits and Drug Resistance. Zheng Q; Zhang M; Zhou F; Zhang L; Meng X Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277 [TBL] [Abstract][Full Text] [Related]
12. The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer. Rodriguez D; Ramkairsingh M; Lin X; Kapoor A; Major P; Tang D Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336602 [TBL] [Abstract][Full Text] [Related]
13. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis. Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells. Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer. Niu T; Zhang W; Xiao W Cancer Cell Int; 2021 Jan; 21(1):31. PubMed ID: 33413418 [TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Stem Cells and Sex Steroid Hormones. Flores-Ramírez I; Baranda-Avila N; Langley E Curr Stem Cell Res Ther; 2019; 14(5):398-404. PubMed ID: 30095060 [TBL] [Abstract][Full Text] [Related]
17. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy. Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells. Hwang-Verslues WW; Lee WH; Lee EY J Mol Biomark Diagn; 2012; Suppl 8():6. PubMed ID: 24977105 [TBL] [Abstract][Full Text] [Related]
19. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions. Singh D; Sahoo A Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38251701 [TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways. Das PK; Rakib MA; Khanam JA; Pillai S; Islam F Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]